P1,P4-di-(2-(3,3,3-trifluoropropylthylthio)-5'-adenosine) P1,P4-dithio-P2,P3-chloromethylenetetraphosphate sodium salt

ID: ALA3746192

Chembl Id: CHEMBL3746192

PubChem CID: 127039918

Max Phase: Preclinical

Molecular Formula: C27H31ClF6N10Na4O16P4S4

Molecular Weight: 1157.24

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  Nc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@H](COP(=O)([S-])OP(=O)([O-])C(Cl)P(=O)([O-])OP(=O)([S-])OC[C@H]2O[C@@H](n3cnc4c(N)nc(SCCC(F)(F)F)nc43)[C@H](O)[C@@H]2O)[C@@H](O)[C@H]1O.[Na+].[Na+].[Na+].[Na+]

Standard InChI:  InChI=1S/C27H35ClF6N10O16P4S4.4Na/c28-23(61(49,50)59-63(53,65)55-5-9-13(45)15(47)21(57-9)43-7-37-11-17(35)39-24(41-19(11)43)67-3-1-26(29,30)31)62(51,52)60-64(54,66)56-6-10-14(46)16(48)22(58-10)44-8-38-12-18(36)40-25(42-20(12)44)68-4-2-27(32,33)34;;;;/h7-10,13-16,21-23,45-48H,1-6H2,(H,49,50)(H,51,52)(H,53,65)(H,54,66)(H2,35,39,41)(H2,36,40,42);;;;/q;4*+1/p-4/t9-,10-,13-,14-,15-,16-,21-,22-,23?,63?,64?;;;;/m1..../s1

Standard InChI Key:  ZGYRUERAHOBLCL-RTUHRPQLSA-J

Associated Targets(Human)

P2RY1 Tchem Purinergic receptor P2Y1 (1327 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
P2RY12 Tclin Purinergic receptor P2Y12 (2369 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
P2RX1 Tchem P2X purinoceptor 1 (328 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 1157.24Molecular Weight (Monoisotopic): 1155.9659AlogP: #Rotatable Bonds:
Polar Surface Area: Molecular Species: HBA: HBD:
#RO5 Violations: HBA (Lipinski): HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: CX LogD:
Aromatic Rings: Heavy Atoms: QED Weighted: Np Likeness Score:

References

1. Yanachkov IB, Chang H, Yanachkova MI, Dix EJ, Berny-Lang MA, Gremmel T, Michelson AD, Wright GE, Frelinger AL..  (2016)  New highly active antiplatelet agents with dual specificity for platelet P2Y1 and P2Y12 adenosine diphosphate receptors.,  107  [PMID:26588064] [10.1016/j.ejmech.2015.10.055]

Source